GOLD Learning Speakers
Amy Holmes, PharmD, BCPPS
- Speaker Type: Pharmacology Lecture Pack 2017, GOLD Neonatal 2018
- Country: USA
Biography:
Amy Holmes has practiced as a pharmacist for 21 years with the last 9 years being focused in neonatal critical care at Novant Health Forsyth Medical Center in Winston Salem, NC. She holds degrees in pharmacy from University of North Carolina (BS) as well as the University of Maryland at Baltimore (PharmD). Amy serves as the Residency Program Director for the acute care PGY1 program at Novant Health Forsyth Medical Center. She is active in state and national pharmacy organizations including the Pediatric Pharmacy Advocacy Group (PPAG) and the American Society of Health-System Pharmacists (ASHP).
CE Library Presentation(s) Available Online:
Medication Use and Breastfeeding
Maternal milk offers many benefits to both mother and baby; however, breastfeeding is often stopped unnecessarily due to uncertainty or fear regarding potential safety issues with medication use in lactation. This presentation will provide information that will assist health care professionals in optimizing resources to make sound decisions regarding medication safety during lactation. There will be discussion on the pharmacologic properties associated with passage of medications into maternal milk including discussion of specific medication examples. We will discuss resources available that provide the most thorough and up to date information on medication use in lactation. Finally, we will discuss the use of galactogogues to augment breast milk production.
Presentations:
6 | Hours / CE Credits: 6
| Viewing Time: 4 Weeks
Hours / CE Credits: 1 (details) | Categories:
(IBCLC) Pharmacology and Toxicology, Medications & Herbs
Updates in Pharmacotherapy for NAS
This presentation will provide a general overview of neonatal abstinence syndrome (NAS) followed by a more detailed discussion of some of the more recently published approaches to treatment. This will include review of alternative dosing strategies for morphine as well as the use of buprenorphine for management of NAS symptoms.
Presentations:
1 | Hours / CE Credits: 1
| Viewing Time: 2 Weeks
Presentations:
11 | Hours / CE Credits: 11.5
| Viewing Time: 8 Weeks
Hours / CE Credits: 1 (details) | Categories:
(IBCLC) Pharmacology and Toxicology, (IBCLC) Research, Neonatal Abstinence Syndrome
